TiGenix (NYSE Euronext: TIG) Financing facility for P3 Crohn’s disease Trial
October 3rd, 2011
No comments
TIG’s wholly-owned subsidiary Cellerix SA is to receive a EUR 4.95M soft loan from the “Madrid Network” to Read more…
Categories: Financing, TiGenix (TIG) combination with Cellerix
